Dynamic PET CT as a Tool for Treatment Efficacy Monitoring in Lung Cancer

NCT02505685 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2016-11-18

No results posted yet for this study

Summary

The purpose of this study is to evaluate the use of Dynamic PET/CT as a tool to assess disease response to anti-cancer therapy in Lung Cancer patients.

Conditions

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Nir Peled, MD PhD FCCP · Rabin Medical Center

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2018-07-31
Completion
2020-07-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02505685 on ClinicalTrials.gov